Today's Bullish Patterns & Technical Sentiment | Published on 04/23: CERT, ATAT, WST and More
Today's List
$Certara (CERT.US)$ climbed 2.9% in the last session. Certara sells regulatory and medical writing business to Veristat for up to $135 million. The 20-day average turnover is $24.24M, indicating active trading. Indicators suggest an Overbought condition with strong sentiment. Watch for selling pressure near $6.71, with $6.34 serving as the pullback support reference.
Date Identified: 2026/04/14
Pattern: Bullish Continuation Wedge
Probability: 87.30%
Return Since Signal: 9.62%
Indicator Status: Overbought
Resistance: $6.71
Support: $6.34
Signal Status: Active
$Atour Lifestyle Holdings (ATAT.US)$ edged higher 5.07% in the last session. Daiwa analyst includes Atour Lifestyle among preferred China consumer stocks. The 20-day average turnover is $45.77M, indicating active trading. Indicators suggest an Overbought condition with strong sentiment. Watch for selling pressure near $43.72, with $40.07 serving as the pullback support reference.
Date Identified: 2026/04/17
Pattern: Double Bottom
Probability: 89.90%
Return Since Signal: 6.96%
Indicator Status: Overbought
Resistance: $43.72
Support: $40.07
Signal Status: New Entry
$West Pharmaceutical Services (WST.US)$ fell 0.11% in the last session. West Pharmaceutical Services raises 2026 adjusted EPS guidance to $8.40-$8.75 after beating Q1 expectations. The 20-day average turnover is $212.61M, indicating active trading. Indicators suggest an Overbought condition with strong sentiment. Watch for selling pressure near $288.49, with $273.02 serving as the pullback support reference.
Date Identified: 2026/04/07
Pattern: Double Bottom
Probability: 89.63%
Return Since Signal: 5.80%
Indicator Status: Overbought
Resistance: $288.49
Support: $273.02
Signal Status: Active
$Denison Mines (DNN.US)$ moved up 7.09% in the last session. The 20-day average turnover is $114.07M, indicating active trading. Indicators suggest an Overbought condition with strong sentiment. Watch for selling pressure near $4.46, with $4.03 serving as the pullback support reference.
Date Identified: 2026/04/17
Pattern: Double Bottom
Probability: 88.62%
Return Since Signal: 5.15%
Indicator Status: Overbought
Resistance: $4.46
Support: $4.03
Signal Status: New Entry
$KLA Corp (KLAC.US)$ climbed 1.49% in the last session. UBS maintains KLA Corp with hold rating, raises target price from $1,575 to $1,835. The 20-day average turnover is $1.33B, indicating active trading. Indicators suggest an Overbought condition with strong sentiment. Watch for selling pressure near $1912.53, with $1803.92 serving as the pullback support reference.
Date Identified: 2026/04/14
Pattern: Triple Bottom
Probability: 91.37%
Return Since Signal: 4.45%
Indicator Status: Overbought
Resistance: $1912.53
Support: $1803.92
Signal Status: Active
More Inclusions
$Hawkins Inc (HWKN.US)$
$Nova (NVMI.US)$
$Artisan Partners Asset Management (APAM.US)$
$SEI Investments (SEIC.US)$
$Klarna Group (KLAR.US)$
$Haemonetics (HAE.US)$
$Energizer Holdings (ENR.US)$
$FactSet Research Systems (FDS.US)$
$Roper Technologies (ROP.US)$
$Cohen & Steers (CNS.US)$
Removals
$Signet Jewelers (SIG.US)$
$Dover (DOV.US)$
$Unum Group (UNM.US)$
$Visteon (VC.US)$
$Ambarella (AMBA.US)$
$Globant (GLOB.US)$
$Willis Towers Watson (WTW.US)$
$Rithm Capital (RITM.US)$
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"
Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business
Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
Crypto prices
More
